139 related articles for article (PubMed ID: 19464773)
1. Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.
Levy Y; Blum S; Levy AP
Clin Nutr; 2009 Oct; 28(5):581-2. PubMed ID: 19464773
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
[TBL] [Abstract][Full Text] [Related]
3. Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy.
Levy AP
Pharmacol Ther; 2006 Nov; 112(2):501-12. PubMed ID: 16854468
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
Levy AP; Blum S
Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1105-11. PubMed ID: 18035926
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E and cardiovascular disease: observational studies.
Gaziano JM
Ann N Y Acad Sci; 2004 Dec; 1031():280-91. PubMed ID: 15753154
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for supplemented antioxidants in the prevention of atherosclerosis?
Katsiki N; Manes C
Clin Nutr; 2009 Feb; 28(1):3-9. PubMed ID: 19042058
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
Antoniades C; Tousoulis D; Tentolouris C; Toutouzas P; Stefanadis C
Herz; 2003 Nov; 28(7):628-38. PubMed ID: 14689123
[TBL] [Abstract][Full Text] [Related]
9. Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.
Hochberg I; Berinstein EM; Milman U; Shapira C; Levy AP
Curr Diab Rep; 2017 Jun; 17(6):42. PubMed ID: 28451949
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
Lonn EM; Yusuf S
Can J Cardiol; 1997 Oct; 13(10):957-65. PubMed ID: 9374952
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
[TBL] [Abstract][Full Text] [Related]
12. No evidence supports vitamin E indiscriminate supplementation.
Dotan Y; Lichtenberg D; Pinchuk I
Biofactors; 2009; 35(6):469-73. PubMed ID: 19866453
[TBL] [Abstract][Full Text] [Related]
13. The 'vitamin E regeneration system' (VERS) and an algorithm to justify antioxidant supplementation in diabetes--a hypothesis.
Nwose EU; Jelinek HF; Richards RS; Kerr PG
Med Hypotheses; 2008; 70(5):1002-8. PubMed ID: 17959321
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E modulation of cardiovascular disease.
Meydani M
Ann N Y Acad Sci; 2004 Dec; 1031():271-9. PubMed ID: 15753153
[TBL] [Abstract][Full Text] [Related]
15. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
16. The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants.
Bassuk SS; Albert CM; Cook NR; Zaharris E; MacFadyen JG; Danielson E; Van Denburgh M; Buring JE; Manson JE
J Womens Health (Larchmt); 2004; 13(1):99-117. PubMed ID: 15006283
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E and thetreatment and prevention of diabetes: a case for a controlled clinical trial.
Halliwell B
Singapore Med J; 2002 Sep; 43(9):479-84. PubMed ID: 12568428
[TBL] [Abstract][Full Text] [Related]
18. Vitamins and cardiovascular disease.
Honarbakhsh S; Schachter M
Br J Nutr; 2009 Apr; 101(8):1113-31. PubMed ID: 18826726
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of lycopene in cardiovascular disease.
Riccioni G; Mancini B; Di Ilio E; Bucciarelli T; D'Orazio N
Eur Rev Med Pharmacol Sci; 2008; 12(3):183-90. PubMed ID: 18700690
[TBL] [Abstract][Full Text] [Related]
20. Update on vitamin supplements for the prevention of coronary disease and stroke.
Pearce KA; Boosalis MG; Yeager B
Am Fam Physician; 2000 Sep; 62(6):1359-66. PubMed ID: 11011864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
